AQP1 and central nervous system cancer: Acetazolamide, a carbonic anhydrase inhibitor, was discovered to suppress AQP1 expression, which shielded tumours from cytotoxic oedema by maintaining extracellular acidity and promoted tumour spread in glioma [91].